Closed
SectorHealthcare
48.15 2.86
24h
Min
46.31
Max
48.89
Income | 165M 132M |
---|---|
Sales | 166M 171M |
P/E Sector Avg | 11.433 63.778 |
EPS | 1.98 |
Profit margin | 77.166 |
Employees | 126 |
EBITDA | 168M 127M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +44.62% upside |
Next Earnings | 5 maj 2025 |
---|
Market Cap | 791M 3B |
---|---|
Previous open | 45.29 |
Previous close | 48.15 |
By Acuity
20%
80%
41 / 386 Ranking in Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 67.8 USD 44.62%
High 82 USD
Low 38 USD
Based on 10 Wall Street analysts offering 12 month price targets forProtagonist Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$